home / stock / gmda / gmda news


GMDA News and Press, Gamida Cell Ltd. From 05/15/23

Stock Information

Company Name: Gamida Cell Ltd.
Stock Symbol: GMDA
Market: NASDAQ

Menu

GMDA GMDA Quote GMDA Short GMDA News GMDA Articles GMDA Message Board
Get GMDA Alerts

News, Short Squeeze, Breakout and More Instantly...

GMDA - Gamida Cell GAAP EPS of -$0.27 in-line

2023-05-15 16:45:12 ET Gamida Cell press release ( NASDAQ: GMDA ): Q1 GAAP EPS of -$0.27 in-line. 2023 Guidance: As of March 31, 2023, Gamida Cell had total cash and cash equivalents of $46.8 million. This amount does not include the approximately $25 million in net pr...

GMDA - Gamida Cell Reports First Quarter 2023 Financial Results and Provides Company Update

Company reports positive feedback and continued progress on transplant center onboarding and payer coverage around launch of Omisirge ® (omidubicel-onlv), a new cell therapy for allogeneic stem cell transplant approved April 17 by the FDA Company successfully completed public off...

GMDA - Notable earnings after Monday's close

2023-05-14 17:35:54 ET Major earnings expected after the bell on Monday include: Danaos Corporation ( DAC ) Canoo ( GOEV ) Arrival ( ARVL ) Cara Therapeutics ( CARA ) Fortuna Silver Mines ( FSM ) For further details see: Notable earnings a...

GMDA - Gamida Cell Announces the Date of Its First Quarter 2023 Financial Results and Webcast

Gamida Cell Ltd. (Nasdaq: GMDA), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced that the company will host a conference call and live audio webcast on Monday, May 15, 2023, at 4:30 p.m. ET to review its first quarter 2023 financial results and provide a...

GMDA - Penny Stocks To Buy Now? 3 To Watch In The Stock Market Today

2023-05-10 12:47:25 ET One of the most frequently asked questions daily is, “What are the best penny stocks to buy now?” This is, of course, subjective to the individual traders. But the process to find them can be similar, and it all starts with building a list of penny stock...

GMDA - Gamida: The Die Is Now Cast

2023-04-28 15:47:36 ET Summary Today, we circle back on Gamida Cell, which recently garnered a long-awaited FDA approval and bolstered its balance sheet. The company also raises new capital and slashes some expenses to support the rollout of the newly approved Omisirge. What c...

GMDA - PBR, SGMO and EHTH among pre-market losers

2023-04-28 08:33:44 ET Hillstream BioPharma ( HILS ) -57% on pricing $2.65M equity offering . Centogene ( CNTG ) -26% receives Nasdaq non-compliance notice . Cloudflare ( NET ) -25% after Q1 earnings release . Snap ( SNAP ) -18% afte...

GMDA - GMDA, TIGO and INAB among pre-market losers

2023-04-27 08:33:26 ET Baudax Bio ( BXRX ) -55% on pricing $4M stock offering at $1.15/share. Impinj ( PI ) -28% after Q1 earning release . Wolfspeed ( WOLF ) -16% as delays from Mohawk Valley facility hurts guidance. Mobileye Global ( MBL...

GMDA - KC, GMDA and CNSP are among pre market gainers

2023-04-20 09:00:52 ET Augmedix ( AUGX ) +91% a nnounces Partnership with HCA Healthcare to Accelerate the Development of AI-enabled Ambient Documentation. United Insurance Holdings  ( UIHC ) +32% . CNS Pharmaceuticals ( CNSP ) +28% . MDxHealth...

GMDA - Vyne, Ensysce top healthcare gainers; Allarity, Femasys lead losers' pack

2023-04-19 10:05:08 ET Gainers: Vyne Therapeutics ( VYNE ) +32% . Ensysce Biosciences ( ENSC ) +23% . Legend Biotech ( LEGN ) +20% . Tempest Therapeutics ( TPST ) +16% . Evoke Pharma ( EVOK ) +14% . Losers: Allarity T...

Previous 10 Next 10